Strides Arcolab has received tentative approval from the US FDA for its anti aids combination drug Tenofovir Disoproxil Fumarate and Emtricitabine Tablets, 300mg and 200mg. The company is one among the 6 generics company to have received USFDA approval. This abbreviated new drug application (ANDA) has been reviewed under the expedited provisions of the President's Emergency Plan for AIDS relief (PEPFAR). The company supplies ARV products to global procurement agencies and this approval adds to the overall basket of medicines available.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
